{
  "catalogId": "6a8c9f2e-11c4-4719-acc9-425afb0dbffb",
  "name": "VIMIZIM",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "154 16 34261 00",
  "treatmentDescriptions": "Vimizim is indicated for the treatment of mucopolysaccharidosis, type IVA (Morquio A Syndrome ,MPS IVA) in patients of all ages.",
  "termsOfIssue": "Prescription required",
  "form": "concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ELOSULFASE ALFA/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "A16AB12",
      "name": "ELOSULFASE ALFA"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VIMIZIM 1MG/ML 1X5MLVIAL",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "7643",
        "yarpa": "53748",
        "pharmasoft": "22383"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 3056.922676,
        "retailMargin": 10.0,
        "maxRetailPrice": 3362.614943,
        "maxPriceWithVAT": 3967.885457
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.400861"
  }
}